Benutzer: Gast  Login
Titel:

Canonical NF-?B signaling in hepatocytes acts as a tumor-suppressor in hepatitis B virus surface antigen-driven hepatocellular carcinoma by controlling the unfolded protein response.

Dokumenttyp:
Journal Article; Research Support, Non-U.S. Gov't; Article
Autor(en):
Sunami, Yoshiaki; Ringelhan, Marc; Kokai, Enikö; Lu, Miao; O'Connor, Tracy; Lorentzen, Anna; Weber, Achim; Rodewald, Ann-Katrin; Müllhaupt, Beat; Terracciano, Luigi; Gul, Sarah; Wissel, Sebastian; Leithäuser, Frank; Krappmann, Daniel; Riedl, Petra; Hartmann, Daniel; Schirmbeck, Reinhold; Strnad, Pavel; Hüser, Norbert; Kleeff, Jörg; Friess, Helmut; Schmid, Roland M; Geisler, Fabian; Wirth, Thomas; Heikenwälder, Mathias
Abstract:
Chronic hepatitis B virus (HBV) infection remains the most common risk factor for hepatocellular carcinoma (HCC). Efficient suppression of HBV viremia and necroinflammation as a result of nucleos(t)ide analogue treatment is able to reduce HCC incidence; nevertheless, hepatocarcinogenesis can occur in the absence of active hepatitis, correlating with high HBV surface antigen (HBsAg) levels. Nuclear factor ?B (NF-?B) is a central player in chronic inflammation and HCC development. However, in the...     »
Zeitschriftentitel:
Hepatology
Jahr:
2016
Band / Volume:
63
Heft / Issue:
5
Seitenangaben Beitrag:
1592-607
Sprache:
eng
Volltext / DOI:
doi:10.1002/hep.28435
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/26892811
Print-ISSN:
0270-9139
TUM Einrichtung:
Chirurgische Klinik und Poliklinik; II. Medizinische Klinik und Poliklinik (Gastroenterologie); Institut für Virologie
 BibTeX